Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,253 | -17,724 | -10,860 | -3,946 | 2,106 |
| Depreciation Amortization | 12 | 28 | 17 | 9 | 4 |
| Accounts payable and accrued liabilities | -706 | 838 | 841 | 1,005 | 521 |
| Other Working Capital | 335 | 1,992 | 1,078 | 1,276 | 534 |
| Other Operating Activity | 1,410 | -5,912 | -6,594 | -7,610 | -7,940 |
| Operating Cash Flow | $-5,202 | $-20,778 | $-15,518 | $-9,266 | $-4,775 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,219 | 2,241 | 10,000 | 5,000 | 3,000 |
| PPE Investments | N/A | -90 | -90 | -8 | -8 |
| Investing Cash Flow | $4,219 | $2,151 | $9,910 | $4,992 | $2,992 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 13,692 | 0 | N/A | N/A |
| Other Financing Activity | -156 | -211 | -210 | -210 | -210 |
| Financing Cash Flow | $-156 | $13,481 | $-210 | $-210 | $-210 |
| Beginning Cash Position | 8,910 | 14,056 | 14,056 | 14,056 | 14,056 |
| End Cash Position | 7,771 | 8,910 | 8,238 | 9,572 | 12,063 |
| Net Cash Flow | $-1,139 | $-5,146 | $-5,818 | $-4,484 | $-1,993 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,202 | -20,778 | -15,518 | -9,266 | -4,775 |
| Capital Expenditure | N/A | -90 | -90 | -8 | -8 |
| Free Cash Flow | -5,202 | -20,868 | -15,608 | -9,274 | -4,783 |